 | • レポートコード：MRC2Q12-16748 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、概日リズム睡眠障害薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 概日リズム睡眠障害薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 概日リズム睡眠障害薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 概日リズム睡眠障害薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの概日リズム睡眠障害薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の概日リズム睡眠障害薬の売上および2028年までの予測に焦点を当てています。 概日リズム睡眠障害薬のグローバル主要企業には、Teva Pharmaceuticals、Takeda Pharmaceutical、NBTY、Vicks (Procter & Gamble)、Natrol、Nature Made (Pharmavite)、Jameison、GNC、By-Health、Now Foods、Vitafusion (Church & Dwight)、OLLY (Unilever)、Doctor's Best (Kingdomway)などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 概日リズム睡眠障害薬市場は、タイプとアプリケーションによって区分されます。世界の概日リズム睡眠障害薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 メラトニン、ラメルテオン、その他 【アプリケーション別セグメント】 睡眠相遅延症候群（DSPS）、進行性睡眠相症候群（ASPS）、不規則睡眠覚醒障害（ISWD）、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 概日リズム睡眠障害薬製品概要 - タイプ別市場（メラトニン、ラメルテオン、その他） - アプリケーション別市場（睡眠相遅延症候群（DSPS）、進行性睡眠相症候群（ASPS）、不規則睡眠覚醒障害（ISWD）、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の概日リズム睡眠障害薬販売量予測2017-2028 - 世界の概日リズム睡眠障害薬売上予測2017-2028 - 概日リズム睡眠障害薬の地域別販売量 - 概日リズム睡眠障害薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別概日リズム睡眠障害薬販売量 - 主要メーカー別概日リズム睡眠障害薬売上 - 主要メーカー別概日リズム睡眠障害薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（メラトニン、ラメルテオン、その他） - 概日リズム睡眠障害薬のタイプ別販売量 - 概日リズム睡眠障害薬のタイプ別売上 - 概日リズム睡眠障害薬のタイプ別価格 ・アプリケーション別市場規模（睡眠相遅延症候群（DSPS）、進行性睡眠相症候群（ASPS）、不規則睡眠覚醒障害（ISWD）、その他） - 概日リズム睡眠障害薬のアプリケーション別販売量 - 概日リズム睡眠障害薬のアプリケーション別売上 - 概日リズム睡眠障害薬のアプリケーション別価格 ・北米市場 - 北米の概日リズム睡眠障害薬市場規模（タイプ別、アプリケーション別） - 主要国別の概日リズム睡眠障害薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの概日リズム睡眠障害薬市場規模（タイプ別、アプリケーション別） - 主要国別の概日リズム睡眠障害薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の概日リズム睡眠障害薬市場規模（タイプ別、アプリケーション別） - 主要国別の概日リズム睡眠障害薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の概日リズム睡眠障害薬市場規模（タイプ別、アプリケーション別） - 主要国別の概日リズム睡眠障害薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの概日リズム睡眠障害薬市場規模（タイプ別、アプリケーション別） - 主要国別の概日リズム睡眠障害薬市場規模（トルコ、サウジアラビア） ・企業情報 Teva Pharmaceuticals、Takeda Pharmaceutical、NBTY、Vicks (Procter & Gamble)、Natrol、Nature Made (Pharmavite)、Jameison、GNC、By-Health、Now Foods、Vitafusion (Church & Dwight)、OLLY (Unilever)、Doctor's Best (Kingdomway) ・産業チェーン及び販売チャネル分析 - 概日リズム睡眠障害薬の産業チェーン分析 - 概日リズム睡眠障害薬の原材料 - 概日リズム睡眠障害薬の生産プロセス - 概日リズム睡眠障害薬の販売及びマーケティング - 概日リズム睡眠障害薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 概日リズム睡眠障害薬の産業動向 - 概日リズム睡眠障害薬のマーケットドライバー - 概日リズム睡眠障害薬の課題 - 概日リズム睡眠障害薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Circadian Rhythm Sleep Disorders Drug estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Circadian Rhythm Sleep Disorders Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Circadian Rhythm Sleep Disorders Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Circadian Rhythm Sleep Disorders Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Circadian Rhythm Sleep Disorders Drug include Teva Pharmaceuticals, Takeda Pharmaceutical, NBTY, Vicks (Procter & Gamble), Natrol, Nature Made (Pharmavite), Jameison, GNC and By-Health, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Circadian Rhythm Sleep Disorders Drug companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Circadian Rhythm Sleep Disorders Drug market. Further, it explains the major drivers and regional dynamics of the global Circadian Rhythm Sleep Disorders Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Teva Pharmaceuticals
Takeda Pharmaceutical
NBTY
Vicks (Procter & Gamble)
Natrol
Nature Made (Pharmavite)
Jameison
GNC
By-Health
Now Foods
Vitafusion (Church & Dwight)
OLLY (Unilever)
Doctor’s Best (Kingdomway)
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Circadian Rhythm Sleep Disorders Drug Segment by Type
Melatonin
Ramelteon
Others
Circadian Rhythm Sleep Disorders Drug Segment by Application
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Circadian Rhythm Sleep Disorders Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Circadian Rhythm Sleep Disorders Drug market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Circadian Rhythm Sleep Disorders Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Circadian Rhythm Sleep Disorders Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Circadian Rhythm Sleep Disorders Drug revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Circadian Rhythm Sleep Disorders Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Circadian Rhythm Sleep Disorders Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva Pharmaceuticals, Takeda Pharmaceutical, NBTY, Vicks (Procter & Gamble), Natrol, Nature Made (Pharmavite), Jameison, GNC and By-Health, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Circadian Rhythm Sleep Disorders Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circadian Rhythm Sleep Disorders Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Circadian Rhythm Sleep Disorders Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Melatonin
1.2.3 Ramelteon
1.2.4 Others
1.3 Market by Application
1.3.1 Global Circadian Rhythm Sleep Disorders Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Delayed Sleep Phase Syndrome (DSPS)
1.3.3 Advanced Sleep Phase Syndrome (ASPS)
1.3.4 Irregular Sleep-Wake Disorder (ISWD)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circadian Rhythm Sleep Disorders Drug Market Perspective (2017-2028)
2.2 Circadian Rhythm Sleep Disorders Drug Growth Trends by Region
2.2.1 Circadian Rhythm Sleep Disorders Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Circadian Rhythm Sleep Disorders Drug Historic Market Size by Region (2017-2022)
2.2.3 Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Region (2023-2028)
2.3 Circadian Rhythm Sleep Disorders Drug Market Dynamics
2.3.1 Circadian Rhythm Sleep Disorders Drug Industry Trends
2.3.2 Circadian Rhythm Sleep Disorders Drug Market Drivers
2.3.3 Circadian Rhythm Sleep Disorders Drug Market Challenges
2.3.4 Circadian Rhythm Sleep Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue
3.1.1 Global Top Circadian Rhythm Sleep Disorders Drug Players by Revenue (2017-2022)
3.1.2 Global Circadian Rhythm Sleep Disorders Drug Revenue Market Share by Players (2017-2022)
3.2 Global Circadian Rhythm Sleep Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circadian Rhythm Sleep Disorders Drug Revenue
3.4 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio
3.4.1 Global Circadian Rhythm Sleep Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circadian Rhythm Sleep Disorders Drug Revenue in 2021
3.5 Circadian Rhythm Sleep Disorders Drug Key Players Head office and Area Served
3.6 Key Players Circadian Rhythm Sleep Disorders Drug Product Solution and Service
3.7 Date of Enter into Circadian Rhythm Sleep Disorders Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Type
4.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Type (2017-2022)
4.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Type (2023-2028)
5 Circadian Rhythm Sleep Disorders Drug Breakdown Data by Application
5.1 Global Circadian Rhythm Sleep Disorders Drug Historic Market Size by Application (2017-2022)
5.2 Global Circadian Rhythm Sleep Disorders Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
6.2 North America Circadian Rhythm Sleep Disorders Drug Market Size by Type
6.2.1 North America Circadian Rhythm Sleep Disorders Drug Market Size by Type (2017-2022)
6.2.2 North America Circadian Rhythm Sleep Disorders Drug Market Size by Type (2023-2028)
6.2.3 North America Circadian Rhythm Sleep Disorders Drug Market Share by Type (2017-2028)
6.3 North America Circadian Rhythm Sleep Disorders Drug Market Size by Application
6.3.1 North America Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2022)
6.3.2 North America Circadian Rhythm Sleep Disorders Drug Market Size by Application (2023-2028)
6.3.3 North America Circadian Rhythm Sleep Disorders Drug Market Share by Application (2017-2028)
6.4 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country
6.4.1 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2017-2022)
6.4.2 North America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
7.2 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Type
7.2.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Type (2017-2022)
7.2.2 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Type (2023-2028)
7.2.3 Europe Circadian Rhythm Sleep Disorders Drug Market Share by Type (2017-2028)
7.3 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Application
7.3.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2022)
7.3.2 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Application (2023-2028)
7.3.3 Europe Circadian Rhythm Sleep Disorders Drug Market Share by Application (2017-2028)
7.4 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country
7.4.1 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2017-2022)
7.4.2 Europe Circadian Rhythm Sleep Disorders Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
8.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Type
8.2.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Application
8.3.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region
8.4.1 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Circadian Rhythm Sleep Disorders Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
9.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Type
9.2.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Type (2017-2022)
9.2.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Type (2023-2028)
9.2.3 Latin America Circadian Rhythm Sleep Disorders Drug Market Share by Type (2017-2028)
9.3 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Application
9.3.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2022)
9.3.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Application (2023-2028)
9.3.3 Latin America Circadian Rhythm Sleep Disorders Drug Market Share by Application (2017-2028)
9.4 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country
9.4.1 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2017-2022)
9.4.2 Latin America Circadian Rhythm Sleep Disorders Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size (2017-2028)
10.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Type
10.2.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Application
10.3.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country
10.4.1 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Circadian Rhythm Sleep Disorders Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Circadian Rhythm Sleep Disorders Drug Introduction
11.1.4 Teva Pharmaceuticals Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.1.5 Teva Pharmaceuticals Recent Developments
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Details
11.2.2 Takeda Pharmaceutical Business Overview
11.2.3 Takeda Pharmaceutical Circadian Rhythm Sleep Disorders Drug Introduction
11.2.4 Takeda Pharmaceutical Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.2.5 Takeda Pharmaceutical Recent Developments
11.3 NBTY
11.3.1 NBTY Company Details
11.3.2 NBTY Business Overview
11.3.3 NBTY Circadian Rhythm Sleep Disorders Drug Introduction
11.3.4 NBTY Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.3.5 NBTY Recent Developments
11.4 Vicks (Procter & Gamble)
11.4.1 Vicks (Procter & Gamble) Company Details
11.4.2 Vicks (Procter & Gamble) Business Overview
11.4.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Disorders Drug Introduction
11.4.4 Vicks (Procter & Gamble) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.4.5 Vicks (Procter & Gamble) Recent Developments
11.5 Natrol
11.5.1 Natrol Company Details
11.5.2 Natrol Business Overview
11.5.3 Natrol Circadian Rhythm Sleep Disorders Drug Introduction
11.5.4 Natrol Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.5.5 Natrol Recent Developments
11.6 Nature Made (Pharmavite)
11.6.1 Nature Made (Pharmavite) Company Details
11.6.2 Nature Made (Pharmavite) Business Overview
11.6.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Disorders Drug Introduction
11.6.4 Nature Made (Pharmavite) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.6.5 Nature Made (Pharmavite) Recent Developments
11.7 Jameison
11.7.1 Jameison Company Details
11.7.2 Jameison Business Overview
11.7.3 Jameison Circadian Rhythm Sleep Disorders Drug Introduction
11.7.4 Jameison Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.7.5 Jameison Recent Developments
11.8 GNC
11.8.1 GNC Company Details
11.8.2 GNC Business Overview
11.8.3 GNC Circadian Rhythm Sleep Disorders Drug Introduction
11.8.4 GNC Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.8.5 GNC Recent Developments
11.9 By-Health
11.9.1 By-Health Company Details
11.9.2 By-Health Business Overview
11.9.3 By-Health Circadian Rhythm Sleep Disorders Drug Introduction
11.9.4 By-Health Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.9.5 By-Health Recent Developments
11.10 Now Foods
11.10.1 Now Foods Company Details
11.10.2 Now Foods Business Overview
11.10.3 Now Foods Circadian Rhythm Sleep Disorders Drug Introduction
11.10.4 Now Foods Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.10.5 Now Foods Recent Developments
11.11 Vitafusion (Church & Dwight)
11.11.1 Vitafusion (Church & Dwight) Company Details
11.11.2 Vitafusion (Church & Dwight) Business Overview
11.11.3 Vitafusion (Church & Dwight) Circadian Rhythm Sleep Disorders Drug Introduction
11.11.4 Vitafusion (Church & Dwight) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.11.5 Vitafusion (Church & Dwight) Recent Developments
11.12 OLLY (Unilever)
11.12.1 OLLY (Unilever) Company Details
11.12.2 OLLY (Unilever) Business Overview
11.12.3 OLLY (Unilever) Circadian Rhythm Sleep Disorders Drug Introduction
11.12.4 OLLY (Unilever) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.12.5 OLLY (Unilever) Recent Developments
11.13 Doctor’s Best (Kingdomway)
11.13.1 Doctor’s Best (Kingdomway) Company Details
11.13.2 Doctor’s Best (Kingdomway) Business Overview
11.13.3 Doctor’s Best (Kingdomway) Circadian Rhythm Sleep Disorders Drug Introduction
11.13.4 Doctor’s Best (Kingdomway) Revenue in Circadian Rhythm Sleep Disorders Drug Business (2017-2022)
11.13.5 Doctor’s Best (Kingdomway) Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer